Statistics for NurExone Biologic Inc. (id:1873 NRX)
Valuation metrics
Market cap
51.72M
Enterprise value
65.55M
Trailing P/E (ttm)
-9.01
Forward P/E
-4.06
PEG ratio
-4.06
Price/Sales (ttm)
Price/Book (mrq)
19.21
Enterprise Value/Revenue
Enterprise Value/EBITDA
-11.47
Overview
Shares outstanding
70.84M
Float
62.93M
Shares short
114.00
% Held by insiders
0.05%
% Held by institutions
0.00%
Average volume (10 days)
94.85K
Average volume (90 days)
Price summary
52-Week low
0.26
52-Week high
1.19
52-Week change
57.53%
Beta
-0.09
50-Day moving average
0.61
200-Day moving average
0.64
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-114.31%
Return on equity
-253.66%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-5,715,366.00
Net income to common (ttm)
-5,786,633.00
Diluted EPS (ttm)
-0.11
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
3.33M
Total cash per share (mrq)
0.04
Total debt (mrq)
34.94K
Total Debt/Equity (mrq)
0.97
Current ratio (mrq)
509.90%
Book value per share (mrq)
0.04
Cash flow
Cash flow statement
-5,250,031.00
Levered free cash flow (LFCF)
-3,349,567.00